Poor
Not Aligned
Patient Risk:
High
Summary
Accurate for Lipitor’s hyperlipidemia indication and general statin classification, but many interaction/safety claims about combining Lipitor with ibuprofen (FDA recommendations, bleeding/liver/kidney/muscle risks, monitoring, and pregnancy/breastfeeding avoidance) are not supported by the provided FDA label excerpts.
Category Scores
Accurate Statements
Lipitor (atorvastatin) is used to treat high cholesterol by reducing low-density lipoprotein (LDL) cholesterol in the blood.
1.2 Hypeerlipidemia: adjunct to diet to reduce elevated total-C and LDL-C (and other lipid parameters).
Lipitor belongs to the class of medications called statins.
5.1 Skeletal Muscle: “Atorvastatin, like other statins …”
Unsupported Statements
Statins work by inhibiting the production of cholesterol in the liver.
Mechanism of action for statins/atorvastatin is not provided in the supplied label excerpts.
The FDA has not issued a specific warning or contraindication for taking Lipitor with ibuprofen.
No supplied FDA label excerpt addresses ibuprofen-specific warnings/contraindications; absence cannot be confirmed from provided text.
Ibuprofen can increase the risk of bleeding when taken with Lipitor.
No provided Lipitor label excerpt describes an ibuprofen interaction or bleeding risk from the combination.
Combining Lipitor with ibuprofen may increase the risk of liver damage.
No provided Lipitor label excerpt describes an ibuprofen interaction; liver warnings provided are not ibuprofen-specific.
Combining Lipitor with ibuprofen may increase the risk of kidney damage.
No provided Lipitor label excerpt describes an ibuprofen interaction or kidney-damage risk from the combination.
Combining Lipitor with ibuprofen may increase the risk of muscle damage.
Label provided discusses statin-associated myopathy risk generally and certain interacting agents, but not ibuprofen-specific muscle-damage interaction.
The FDA recommends that patients taking Lipitor should not take ibuprofen or other NSAIDs without consulting a doctor or healthcare provider.
No FDA label excerpt provided includes this recommendation regarding NSAIDs/ibuprofen.
The combination of Lipitor and ibuprofen may increase the risk of bleeding.
No ibuprofen-specific interaction warning for bleeding is included in provided excerpts.
The combination of Lipitor and ibuprofen may increase the risk of liver damage.
No ibuprofen-specific interaction warning for liver damage is included in provided excerpts.
Patients taking Lipitor and ibuprofen should be closely monitored for signs of adverse effects.
No provided label excerpt provides monitoring instructions for ibuprofen coadministration.
Alternative medication options for pain relief while taking Lipitor may include acetaminophen.
No provided Lipitor label excerpt discusses alternative analgesics while taking Lipitor.
Alternative medication options for pain relief while taking Lipitor may include low-dose aspirin for patients with a history of cardiovascular disease or stroke.
No provided Lipitor label excerpt discusses aspirin as an alternative analgesic in that context.
Alternative medication options for inflammatory conditions while taking Lipitor may include corticosteroids.
No provided Lipitor label excerpt discusses corticosteroids as alternatives during Lipitor therapy.
It is generally recommended to avoid taking Lipitor with ibuprofen if a person has high blood pressure.
No provided Lipitor label excerpt links ibuprofen avoidance to high blood pressure.
Both Lipitor and ibuprofen can increase blood pressure.
No provided Lipitor label excerpt addresses blood pressure effects of atorvastatin or interaction with ibuprofen.
Common signs of adverse effects when taking Lipitor and ibuprofen together may include bleeding, liver damage, kidney damage, muscle damage, and stomach upset.
No provided Lipitor label excerpt provides an ibuprofen+Lipitor-specific adverse-effect sign list.
It is generally recommended to avoid taking Lipitor with ibuprofen during pregnancy or breastfeeding.
Provided pregnancy/nursing excerpts address atorvastatin in pregnancy/lactation but do not mention ibuprofen-specific coadministration restrictions.
The duration of taking Lipitor with ibuprofen depends on individual circumstances and medical condition.
No provided Lipitor label excerpt provides guidance on duration of Lipitor when coadministered with ibuprofen.
Contradictions
Important Omissions
Label-supported alternatives/restrictions are limited to the supplied excerpts; interaction guidance provided in the label relates to specific interacting agents (e.g., CYP3A4 strong inhibitors, cyclosporine, etc.), but the response’s ibuprofen-focused safety guidance is absent from label-supported content.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
High
Numerous claims about ibuprofen coadministration risks and FDA recommendations are not supported by the provided FDA label excerpts, which could lead to inappropriate avoidance or misunderstanding of true label-based interaction guidance.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
High |
Recommendation
Not Aligned
Primary Issue
Major unsupported interaction and safety claims specifically about ibuprofen + Lipitor, including alleged FDA recommendations, risk of bleeding/liver/kidney/muscle damage, monitoring instructions, and pregnancy/breastfeeding avoidance with ibuprofen.
Suggested Improvement
Remove or replace ibuprofen-specific claims with only label-supported information. If discussing interactions, limit to the specific interacting agents and precautions actually present in the provided label excerpts (e.g., statin skeletal muscle risk and liver enzyme monitoring; interacting agents listed under Drug Interactions/Warned agents).